Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03671213 · ClinicalTrials.gov registry record · NA

Calypso Knee System Clinical Study

A NA study of Osteoarthritis, Knee, sponsored by Moximed.

Completed
Registry status
NA
Development phase
81
Enrollment target
5
Study locations

NCT03671213 is a NA study of Osteoarthritis, Knee that has completed, run by Moximed. The registered enrollment target is 81 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03671213, a NA study of Osteoarthritis, Knee, has completed, sponsored by Moximed.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
5
Study locations

Study Summary

A clinical study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.

Conditions Studied

Interventions

  • DEVICE Calypso Knee System (Implantable Shock Absorber)

Study Locations (5)

Missouri

  • Missouri Orthopaedic Institute - Columbia

New York

  • Hospital for Special Surgery - New York

Ohio

  • Jameson Crane Sports Medicine Institute - Columbus

Oregon

  • Oregon Health and Science University - Portland

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2018-09-19
Est. Completion 2025-03-14
Phase NA

Sponsor

Moximed

4 total trials

What the Registry Record Tells You About NCT03671213

The ClinicalTrials.gov registry entry for NCT03671213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (86% lower). The listed sponsor is Moximed, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Calypso Knee System (Implantable Shock Absorber) is the first listed.

NCT03671213 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Missouri, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT03671213 about?

NCT03671213 is a clinical study titled "Calypso Knee System Clinical Study". A clinical study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.

What is the current status of trial NCT03671213?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2018-09-19. Estimated completion is 2025-03-14.

What conditions does trial NCT03671213 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT03671213?

The interventions under investigation include: Calypso Knee System (Implantable Shock Absorber) (DEVICE).

Who is sponsoring clinical trial NCT03671213?

This trial is sponsored by Moximed, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03671213 being conducted?

This trial has 5 study locations across Missouri, New York, Ohio, Oregon, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.